13-Fluorolysergol

Pharmaceutical compound From Wikipedia, the free encyclopedia

13-Fluorolysergol, specifically as the (+)-enantiomer (+)-13-fluorolysergol, is a selective serotonin 5-HT2A receptor weak partial agonist or antagonist of the ergoline family.[1][2] It is highly selective for activation of the serotonin 5-HT2A receptor over the serotonin 5-HT2B and 5-HT2C receptors (EC50Tooltip half-maximal effective concentration = >10,000 nM).[1][2] (+)-13-Fluorolysergol has relatively weak maximal efficacy in activating the serotonin 5-HT2A receptor (EmaxTooltip maximal efficacy = 17%).[1][2] It is a derivative of lysergol.[1][2]

Other names(13-Fluoro-6-methyl-9,10-didehydroergolin-8β-yl)methanol
PubChem CID
FormulaC16H17FN2O
Quick facts Clinical data, Other names ...
13-Fluorolysergol
Clinical data
Other names(13-Fluoro-6-methyl-9,10-didehydroergolin-8β-yl)methanol
Drug classSelective serotonin 5-HT2A receptor weak partial agonist or antagonist
Identifiers
  • [(6aR,9R)-2-fluoro-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinolin-9-yl]methanol
PubChem CID
Chemical and physical data
FormulaC16H17FN2O
Molar mass272.323 g·mol−1
3D model (JSmol)
  • CN1C[C@@H](C=C2[C@H]1CC3=CNC4=CC(=CC2=C34)F)CO
  • InChI=1S/C16H17FN2O/c1-19-7-9(8-20)2-12-13-4-11(17)5-14-16(13)10(6-18-14)3-15(12)19/h2,4-6,9,15,18,20H,3,7-8H2,1H3/t9-,15-/m1/s1
  • Key:UBKCOUCTZVGLJQ-RFAUZJTJSA-N
Close

See also

References

Related Articles

Wikiwand AI